Thursday, July 29, 2021

FDA allows automatic 'generic' swap for brand-name insulin

FDA allows automatic 'generic' swap for brand-name insulin

It's the FDA's first approval of an "interchangeable" biosimilar, a near-copy of an injected biologic medicine that's manufactured inside living cells.

Read More >


No comments:

Post a Comment